2m 2m 2m 2m 2m 2m 2m
Biogen (BIIB)
NASDAQ
$217.38+$0.59 (+0.27%)
Price as of Aug 21, 2026 7:30 PM EDT- $32.0BMarket Cap
- 55.61%1-Year Change
- Drug Manufacturers - GeneralIndustry
Biogen (BIIB)
$217.38+$0.59 (+0.27%)
Earnings Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 5.28% | ||
12-Month Momentum | 44.21% | ||
3-Month Risk Adjusted Momentum | 29.24% | ||
12-Month Risk Adjusted Momentum | 128.12% |
True Yield
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -4.06% |
Financial Health Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 8 |